SAB Biotherapeutics (SABS) Other Accumulated Expenses (2020 - 2026)
SAB Biotherapeutics (SABS) posted Other Accumulated Expenses of $1.61 million for Q2 2026, up 98.5% from $808,363 a year earlier and up 59.2% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics' Other Accumulated Expenses came in at $850,000, up 62.9% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 56.3% (FY2020 to FY2025).
- In prior years, SAB Biotherapeutics' Other Accumulated Expenses was $521,639 in FY2024 (+8.6%), $480,435 in FY2023 (-6.4%), $513,110 in FY2022 (+80.7%) and $283,909 in FY2021 (+212.0%).
- Quarterly Other Accumulated Expenses has run from a low of $200,000 in Q1 2023 to a high of $1.7 million in Q3 2024 over five years.
- On a year-over-year basis, Other Accumulated Expenses has increased in each of the last three quarters, with growth averaging 149.1% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2024, with growth of 708.7%; the weakest was Q1 2023, with a decline of 40.6%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $1.01 million (Q1 2026), $850,000 (Q4 2025) and $1.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | SAB Biotherapeutics | 248.81 Mn | 248.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 850,000.00 |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 808,363.00 |
| Mar 31, 2025 | 743,100.00 |
| Dec 31, 2024 | 521,639.00 |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 219,999.00 |
| Mar 31, 2024 | 641,334.00 |
| Dec 31, 2023 | 480,435.00 |
| Sep 30, 2023 | 210,000.00 |
| Jun 30, 2023 | 273,521.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 513,110.00 |
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | 343,102.00 |
| Mar 31, 2022 | 336,619.00 |
| Dec 31, 2021 | 283,909.00 |
| Dec 31, 2020 | 90,982.00 |
API Access
SAB Biotherapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();